PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46
Media Pack
News

Current Edition

Volume 7 Issue 4
Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025
news

Allergan’s eye drug stacks up against Lucentis, but wider market still iffy

Allergan on Thursday touted data from two late-stage trials that showed a drug it in-licensed from a Swiss biotech proved non-inferior to Lucentis in the treatment...
20 July 2018 news Allergan | Drug
Continue Reading →
news

Novartis picks up IL-17 inhibitor in deal worth over $1B

Novartis on Thursday inked a deal for development and commercialization rights to MOR106, an interleukin (IL)-17C inhibitor for the treatment of atopic dermatitis ...
20 July 2018 news Novartis
Continue Reading →
news

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gam...
20 July 2018 news advance | announce
Continue Reading →
news

Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies

Immatics and Genmab to Combine Proprietary Technologies to Create Transformative Bispecific Therapies against Novel, Proprietary Tumor Targets Immatics to Receiv...
13 July 2018 news enters | genmab
Continue Reading →
news

PharmaKrysto announces licensing agreement with Rutgers University for new treatment for people with cystinuria

PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today that it has completed an exclusive global licensing deal with Rutgers University,...
13 July 2018 news agreement | Announces
Continue Reading →
news

ANTABIO Completes € 12.5M Series A

New investors Omnes, BNP Paribas Développement and Sham Innovation Santé invest an additional €5.2M on top of the €7.3M first closing announced in October 2017 Antab...
13 July 2018 news 12.5m | ANTABIO
Continue Reading →
news

Xbrane and STADA enter into a co-development agreement for Xlucane

Xbrane Biopharma AB ("Xbrane") and STADA Arzneimittel AG ("STADA") have entered into a co-development agreement for Xlucane, a Lucentis® (ranibizumab) biosimilar. ...
13 July 2018 news agreement | co-development
Continue Reading →
news

Qiagen to expand biomarker research in UK

The new health innovation campus will support the continued growth of businesses which are driving the future shape of medicine and health care. Qiagen has announce...
13 July 2018 news biomarker | Expand
Continue Reading →
news

Merck inks deal with China’s Xian Janssen for type 2 diabetes drug

China has more than 114 million people living with diabetes, the largest number of any country in the world Global drug giant, Merck signed an agreement with Chi...
13 July 2018 news 2 | China's Xian
Continue Reading →
news

Global Bioinformatics network PRASM to List on CoinBene

PRASM is a decentralized AI-based bioinformatics network and its protocol stores and utilizes biometrics on a blockchain database. According to PRASM, the biometr...
13 July 2018 news bioinformatics | Coinbene
Continue Reading →
Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2025, All Rights Reserved – Powered by Teksyte